← Eichor
Condition: Genodermatosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Genodermatosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genode
Phase 2 · 2 location(s) · Centre Hospitalier Universitaire de Nice · NCT06136403Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Phase N/A · 1 location(s) · Maastricht University Medical Center · NCT06330350A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Phase 2 · 4 location(s) · Centre Hospitalier Universitaire de Nice · NCT06509984
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.